Economic Analysis of R&D Financing : A Case of Pharmaceutical Industry
| Project/Area Number |
09630050
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
経済政策(含経済事情)
|
|---|
| Research Institution | KEIO UNIVERSITY |
|---|
Principal Investigator |
ANEGAWA Tomofumi Keio University, Graduate School of Business Administration, Associate Professor., 大学院・経営管理研究科, 助教授 (80159417)
|
|---|
| Project Period (FY) |
1997 – 1998
|
| Project Status |
Completed (Fiscal Year 1998)
|
| Budget Amount *help |
¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1998: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1997: ¥1,200,000 (Direct Cost: ¥1,200,000)
|
|---|
| Keywords | R&D / profit / accounting return / economic return / value / price regulation / social overhead capital / R&D投資 / q理論 / キャッシュ・フロー / オプション理論 / 製薬産業 |
|---|
| Research Abstract |
Summary
This study investigates financing decision of R&D of pharmaceutical firms. R&D investment is determined by the profitability of the R&D project and cash generated by a firm. To value R&D project, one must measure the role of cash flow profile of a pharmaceutical firms. I first examined the measurement of profitability of R&D investment by distinguishing accounting return from economic return. Second, I examined the effects of price regulation on demand, profitability of R&D project. Although Japanese price regulation is intended to restrain the expenditure of pharmaceuticals, Japanese pharmaceutical firms expanded their sales by substituting new products for old ones. Third, I investigate the economic roles of social overhead capital in R&D financing.
|
Report
(3 results)
Research Products
(15 results)
